IO102/IO103
23-098
Phase 2 small_molecule active
Quick answer
IO102/IO103 for Melanoma is a Phase 2 program (small_molecule) at IO Biotech with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Melanoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active